Zhelnin Kristen, Xue Yue, Quigley Brian, Reid Michelle D, Choi Hyejeong, Memis Bahar, Adsay Volkan, Krasinskas Alyssa M
*Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA †Department of Pathology, College of Medicine, Ulsan University, Ulsan, Republic of Korea.
Am J Surg Pathol. 2017 Jan;41(1):116-120. doi: 10.1097/PAS.0000000000000745.
Mucinous cystic neoplasms (MCNs) can occur in the pancreas and liver. Classically, these cystic lesions are lined by columnar mucinous epithelium with underlying ovarian-type stroma. It has been proposed that cysts with ovarian-type stroma and nonmucinous epithelium be considered separate entities in both the pancreas and liver. Using a series of 104 pancreatic and 32 hepatic cases, we aimed to further characterize the epithelium present in MCNs. Mucinous epithelium was defined as pancreatic intraepithelial neoplasia-like columnar cells with pale pink/clear apical mucin. Epithelial cells ranging from flat to cuboidal to short columnar without obvious mucin or goblet cells were classified as nonmucinous/biliary epithelium. A mixture (at least 5%) of mucinous and nonmucinous/biliary epithelium was noted in 81%. Almost half (47%) of the cases had abundant (>50%) nonmucinous/biliary epithelium. Of the 71 cases with ≤50% nonmucinous/biliary epithelium, 8 cases demonstrated high-grade dysplasia (7 pancreas, 1 liver) and 14 demonstrated invasive adenocarcinoma (11 pancreas, 3 liver). Conversely, of the 58 cases with >50% nonmucinous/biliary epithelium, not a single case of high-grade dysplasia (P=0.007) or invasive carcinoma (P<0.001) was identified. In summary, nonmucinous/biliary epithelium frequently occurs in MCNs of the pancreas and liver. As mucinous and nonmucinous/biliary epithelia often occur together, there does not appear to be enough evidence to regard cases with predominantly nonmucinous/biliary epithelium as separate entities. Our findings suggest that mucinous change is a "progression" phenomenon in MCNs of the pancreas and liver, and only when abundant mucinous epithelium is present is there a risk of progression to malignancy.
黏液性囊性肿瘤(MCNs)可发生于胰腺和肝脏。典型情况下,这些囊性病变内衬柱状黏液上皮,其下有卵巢型间质。有人提出,具有卵巢型间质和非黏液性上皮的囊肿在胰腺和肝脏中应被视为不同的实体。我们对104例胰腺病例和32例肝脏病例进行了研究,旨在进一步明确MCNs中存在的上皮类型。黏液性上皮被定义为具有淡粉色/清亮顶端黏液的胰腺上皮内瘤变样柱状细胞。上皮细胞从扁平到立方再到短柱状,无明显黏液或杯状细胞的,被归类为非黏液性/胆管上皮。81%的病例中可见黏液性和非黏液性/胆管上皮的混合(至少5%)。几乎一半(47%)的病例有丰富(>50%)的非黏液性/胆管上皮。在非黏液性/胆管上皮≤50%的71例病例中,8例表现为高级别异型增生(7例胰腺病例,1例肝脏病例),14例表现为浸润性腺癌(11例胰腺病例,3例肝脏病例)。相反,在非黏液性/胆管上皮>50%的58例病例中,未发现一例高级别异型增生(P = 0.007)或浸润性癌(P<0.001)。总之,非黏液性/胆管上皮在胰腺和肝脏的MCNs中经常出现。由于黏液性和非黏液性/胆管上皮常同时存在,似乎没有足够的证据将以非黏液性/胆管上皮为主的病例视为不同的实体。我们的研究结果表明,黏液性改变是胰腺和肝脏MCNs中的一种“进展”现象,只有当存在丰富的黏液性上皮时,才有可能进展为恶性肿瘤。